Coleman Glenn

Executive buyer

EVP & Chief Financial Officer · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Every open-market stock purchase Coleman Glenn has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.

Total bought
$3.0K
Open-market buys
1
Companies
1
Last buy
Sep 30, 2026

Where the buys stand today

  • CRL
    CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

    One purchase totalling $3.0K at an average of $297.43 per share. See all insider buying in CRL →

    Avg price paid
    $297.43
    Latest price
    —
    Market cap
    Unknown

All reported buys

DateTickerSharesPriceValueFiling
Sep 30, 202610$297.43$3.0KSEC ↗

Follow new qualifying clusters involving Coleman Glenn or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

About this data

Figures are parsed from Coleman Glenn's Form 4 filings on SEC EDGAR (CIK 1434369) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.